1. Home
  2. ADAP vs LGCB Comparison

ADAP vs LGCB Comparison

Compare ADAP & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • LGCB
  • Stock Information
  • Founded
  • ADAP 2008
  • LGCB 2011
  • Country
  • ADAP United Kingdom
  • LGCB Japan
  • Employees
  • ADAP N/A
  • LGCB N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • LGCB
  • Sector
  • ADAP Health Care
  • LGCB
  • Exchange
  • ADAP Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • ADAP 21.3M
  • LGCB 20.0M
  • IPO Year
  • ADAP 2015
  • LGCB 2023
  • Fundamental
  • Price
  • ADAP $0.06
  • LGCB $2.27
  • Analyst Decision
  • ADAP Hold
  • LGCB
  • Analyst Count
  • ADAP 6
  • LGCB 0
  • Target Price
  • ADAP $1.02
  • LGCB N/A
  • AVG Volume (30 Days)
  • ADAP 89.0M
  • LGCB 6.3K
  • Earning Date
  • ADAP 08-13-2025
  • LGCB 07-03-2025
  • Dividend Yield
  • ADAP N/A
  • LGCB N/A
  • EPS Growth
  • ADAP N/A
  • LGCB N/A
  • EPS
  • ADAP N/A
  • LGCB N/A
  • Revenue
  • ADAP $65,084,999.00
  • LGCB $8,993,265.00
  • Revenue This Year
  • ADAP N/A
  • LGCB N/A
  • Revenue Next Year
  • ADAP $52.35
  • LGCB N/A
  • P/E Ratio
  • ADAP N/A
  • LGCB N/A
  • Revenue Growth
  • ADAP N/A
  • LGCB 5.80
  • 52 Week Low
  • ADAP $0.05
  • LGCB $1.22
  • 52 Week High
  • ADAP $1.33
  • LGCB $19.00
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 29.42
  • LGCB 41.09
  • Support Level
  • ADAP $0.05
  • LGCB $2.20
  • Resistance Level
  • ADAP $0.09
  • LGCB $2.51
  • Average True Range (ATR)
  • ADAP 0.01
  • LGCB 0.09
  • MACD
  • ADAP 0.00
  • LGCB -0.04
  • Stochastic Oscillator
  • ADAP 7.21
  • LGCB 27.87

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks: